Tags

Type your tag names separated by a space and hit enter

Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
J Am Acad Dermatol. 2020 Sep; 83(3):928-930.JA

Authors+Show Affiliations

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Electronic address: Ellen.Kim@uphs.upenn.edu.Department of Dermatology, Columbia University, New York, New York.Department of Dermatology, Northwestern University, Chicago, Illinois.Division of Dermatology, City of Hope, Duarte, California.Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.Division of Dermatology, Washington University in St. Louis School of Medicine, Saint Louis, Missouri.Helsinn Therapeutics (US), Inc, Iselin, NJ.Helsinn Therapeutics (US), Inc, Iselin, NJ.ICON Commercialization & Outcomes, Dublin, Ireland.ICON Commercialization & Outcomes, Dublin, Ireland.

Pub Type(s)

Letter
Observational Study

Language

eng

PubMed ID

32089294

Citation

Kim, Ellen J., et al. "Real-world Experience With Mechlorethamine Gel in Patients With Mycosis Fungoides-cutaneous Lymphoma: Preliminary Findings From a Prospective Observational Study." Journal of the American Academy of Dermatology, vol. 83, no. 3, 2020, pp. 928-930.
Kim EJ, Geskin L, Guitart J, et al. Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study. J Am Acad Dermatol. 2020;83(3):928-930.
Kim, E. J., Geskin, L., Guitart, J., Querfeld, C., Girardi, M., Musiek, A., Mink, D. R., Williams, M. J., Angello, J. T., & Bailey, W. L. (2020). Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study. Journal of the American Academy of Dermatology, 83(3), 928-930. https://doi.org/10.1016/j.jaad.2019.12.070
Kim EJ, et al. Real-world Experience With Mechlorethamine Gel in Patients With Mycosis Fungoides-cutaneous Lymphoma: Preliminary Findings From a Prospective Observational Study. J Am Acad Dermatol. 2020;83(3):928-930. PubMed PMID: 32089294.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study. AU - Kim,Ellen J, AU - Geskin,Larisa, AU - Guitart,Joan, AU - Querfeld,Christiane, AU - Girardi,Michael, AU - Musiek,Amy, AU - Mink,David R, AU - Williams,Michael J, AU - Angello,James T, AU - Bailey,William L, Y1 - 2020/02/20/ PY - 2018/07/16/received PY - 2019/12/15/revised PY - 2019/12/23/accepted PY - 2020/2/25/pubmed PY - 2021/2/25/medline PY - 2020/2/25/entrez SP - 928 EP - 930 JF - Journal of the American Academy of Dermatology JO - J Am Acad Dermatol VL - 83 IS - 3 SN - 1097-6787 UR - https://www.unboundmedicine.com/medline/citation/32089294/Real_world_experience_with_mechlorethamine_gel_in_patients_with_mycosis_fungoides_cutaneous_lymphoma:_Preliminary_findings_from_a_prospective_observational_study_ DB - PRIME DP - Unbound Medicine ER -